{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:56:32Z","timestamp":1783702592875,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myasthenia gravis (MG) is an autoimmune disease affecting the postsynaptic membrane at the neuromuscular junction. Anxiety disorder and depression are common psychiatric comorbidities in patients with MG. However, the potential causal relationship between MG and these mental health conditions remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was first conducted to collect relevant data from 96 patients with MG at the time of their initial definitive diagnosis at our center. The cohort was divided into an anxiety group and a non-anxiety group, and into a depression group and a non-depression group. Statistical methods were employed to examine the relationship between MG scale scores and the presence of anxiety and depression. Subsequently, for the first time, we employed a bidirectional two-sample Mendelian Randomization (MR) approach to explore the causal relationships between MG, anxiety disorders, and depression. We utilized the largest and most recent European population genome-wide association studies available for the three phenotypes to extract genetic variants that could serve as instrumental variables. The inverse variance weighted model was used as the primary analysis method. Multiple sensitivity analyses and pleiotropy tests were conducted to validate the robustness of the primary findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In clinical studies, it was observed that 62.5% of MG patients exhibited anxiety symptoms, while 46.90% presented depressive symptoms with myasthenia gravis (MG). Through univariate regression analysis, no direct associations were identified between gender, age, disease duration, or MGFA classification and the occurrence of anxiety and depression. However, Quantitative Myasthenia Gravis (QMG) Score and Myasthenia Gravis Activities of Daily Living (MG-ADL) score were significantly associated with anxiety and depression among patients with MG (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). After adjusting for confounding variables, each one-point increase in the QMG score was associated with a 11.9% higher risk of anxiety and a 15.7% higher risk of depression, and each one-point increase in the MG-ADL score, the risk of anxiety and depression increases by 22.5 and 18.5%. These findings suggest that more severe MG symptoms and reduced quality of life are more likely to be accompanied by anxiety and depression. Further Mendelian randomization (MR) analyses provided no evidence supporting the hypothesis that genetically predicted MG influences the risk of anxiety disorders or depression. Reverse MR analysis also failed to reveal any causal relationship between these psychiatric comorbidities and MG. Sensitivity and pleiotropy analyses confirmed the robustness of our results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In real-world clinical research, patients with MG who have more severe disease are more likely to present with anxiety and depression, and the two conditions show a clear association. However, from a genetic perspective, Mendelian Randomization (MR) analysis does not support a causal relationship between MG and anxiety or depression in European populations. The correlation observed in our clinical research may reflect non-causal associations not explained by genetic liability, potentially involving shared genetic architecture or non-genetic mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1791340","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:39:33Z","timestamp":1773812373000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Myasthenia gravis and anxiety-depression states: an integrated clinical and Mendelian randomization study"],"prefix":"10.3389","volume":"17","author":[{"given":"Lijun","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Neurology, Wuhan No. 1 Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical Medical Institute, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Ye","sequence":"additional","affiliation":[{"name":"The First Clinical Medical Institute, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan No. 1 Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan No. 1 Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zeng","sequence":"additional","affiliation":[{"name":"The First Clinical Medical Institute, Hubei University of Chinese Medicine","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan No. 1 Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3760\/cma.j.cn113694-20250120-00041","article-title":"Chinese guideline for diagnosis and treatment of myasthenia gravis (2025 edition)","volume":"58","year":"2025","journal-title":"Chin J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000539577","article-title":"Prevalence, incidence, and mortality of myasthenia gravis and myasthenic syndromes: a systematic review","volume":"59","author":"Sciancalepore","year":"2025","journal-title":"Neuroepidemiology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e68104","DOI":"10.1136\/bmjopen-2022-068104","article-title":"Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)","volume":"13","author":"Berrih-Aknin","year":"2023","journal-title":"BMJ Open"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2840","DOI":"10.1002\/brb3.2840","article-title":"Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta-analysis","volume":"13","author":"Nadali","year":"2023","journal-title":"Brain Behav"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00415-020-09767-7","article-title":"Depression in myasthenia gravis: a heterogeneous and intriguing entity","volume":"267","author":"Gavrilov","year":"2020","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mus.26719","article-title":"Severity and depression can impact quality of life in patients with myasthenia gravis","volume":"61","author":"Alanazy","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ene.14057","article-title":"Chronic stress, depression and personality type in patients with myasthenia gravis","volume":"27","author":"Bogdan","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2108672119","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","article-title":"Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions","volume":"22","author":"Howard","year":"2019","journal-title":"Nat Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41467-018-03819-3","article-title":"Genome-wide association study of depression phenotypes in UK biobank identifies variants in excitatory synaptic pathways","volume":"9","author":"Howard","year":"2018","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","article-title":"Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression","volume":"50","author":"Wray","year":"2018","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1279845","DOI":"10.3389\/fimmu.2023.1279845","article-title":"Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study","volume":"14","author":"Sheng","year":"2023","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-022-03691-2","article-title":"Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study","volume":"20","author":"Xiao","year":"2022","journal-title":"J Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"102254","DOI":"10.1016\/j.arr.2024.102254","article-title":"Associations of environmental factors with neurodegeneration: an exposome-wide Mendelian randomization investigation","volume":"95","author":"Li","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e209776","DOI":"10.1212\/WNL.0000000000209776","article-title":"Association of genetically predicted anxiety and depression with functional outcome after ischemic stroke: a Mendelian randomization study","volume":"103","author":"Zhang","year":"2024","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13019-022-02081-5","article-title":"Anxiety and depression in thymoma patients in China before surgery","volume":"17","author":"Li","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12883-020-01802-4","article-title":"Prospective study of stress, depression and personality in myasthenia gravis relapses","volume":"20","author":"Bogdan","year":"2020","journal-title":"BMC Neurol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12325-023-02704-w","article-title":"The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population","volume":"41","author":"Dewilde","year":"2024","journal-title":"Adv Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jocn.2015.01.022","article-title":"Clinical features and impact of myasthenia gravis disease in Australian patients","volume":"22","author":"Blum","year":"2015","journal-title":"J Clin Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1015349","DOI":"10.3389\/fpsyt.2022.1015349","article-title":"Neuroimmune mechanisms in fear and panic pathophysiology","volume":"13","author":"McMurray","year":"2022","journal-title":"Front Psych"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e209128","DOI":"10.1212\/WNL.0000000000209128","article-title":"Mendelian randomization applied to neurology: promises and challenges","volume":"102","author":"Gagnon","year":"2024","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","article-title":"Investigating pleiotropy between depression and autoimmune diseases using the UK biobank","volume":"1","author":"Glanville","year":"2021","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.jns.2022.120268","article-title":"The humanistic burden of myasthenia gravis: a systematic literature review","volume":"437","author":"Gelinas","year":"2022","journal-title":"J Neurol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1110499","DOI":"10.3389\/fimmu.2023.1110499","article-title":"Inflammation and autoimmune myasthenia gravis","volume":"14","author":"Huda","year":"2023","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"122287","DOI":"10.1016\/j.lfs.2023.122287","article-title":"Targeting HIF-1\u03b1 alleviates the inflammatory responses and rebuilds the CD4(+) T cell subsets balance in the experimental autoimmune myasthenia gravis inflammation model via regulating cellular and humoral immunity","volume":"336","author":"Yu","year":"2024","journal-title":"Life Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1648020","DOI":"10.3389\/fimmu.2025.1648020","article-title":"Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling","volume":"16","author":"Bhandage","year":"2025","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1356300","DOI":"10.3389\/fneur.2024.1356300","article-title":"IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model","volume":"15","author":"Miyake","year":"2024","journal-title":"Front Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/imm.13597","article-title":"An immunogenetic investigation of 30 autoimmune and autoinflammatory diseases and their links to psychiatric disorders in a nationwide sample","volume":"168","author":"Nudel","year":"2023","journal-title":"Immunology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e301706","DOI":"10.1136\/bmjment-2025-301706","article-title":"Affective disorders and chronic inflammatory conditions: analysis of 1.5 million participants in our future health","volume":"28","author":"Mudra","year":"2025","journal-title":"BMJ Ment Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"100992","DOI":"10.1016\/j.eclinm.2021.100992","article-title":"Role of inflammation in depression and anxiety: tests for disorder specificity, linearity and potential causality of association in the UK biobank","volume":"38","author":"Ye","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamapsychiatry.2024.2185","article-title":"Inflammatory biomarkers and risk of psychiatric disorders","volume":"81","author":"Zeng","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbi.2024.08.048","article-title":"The inflammatory underpinning of depression: an historical perspective","volume":"122","author":"Yirmiya","year":"2024","journal-title":"Brain Behav Immun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e2412556","DOI":"10.1002\/advs.202412556","article-title":"Microglia-derived interleukin-6 triggers astrocyte apoptosis in the hippocampus and mediates depression-like behavior","volume":"12","author":"Shen","year":"2025","journal-title":"Adv Sci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1791340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:39:35Z","timestamp":1773812375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1791340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":41,"alternative-id":["10.3389\/fneur.2026.1791340"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1791340","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"1791340"}}